Toggle menu

FALCON

Start date:
November 2020
Main trial site:
Royal Infirmary of Edinburgh

FALCON is a multi-centre diagnostic study that aims to test the accuracy of a COVID viral detection test that hopes to lead to the development of a point-of-care diagnostic device.

Patients give two sets of samples, one swab and one swab and a saliva samples.  One of these samples sets is sent for the testing via the current standard, PCR, and the other is tested using mass spectrometry.

Research Team

Caroline Blackstock

AMU Senior Research Nurse

More EMERGE Trials

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2 Trial

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.

Read more

NOVEL Study

Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions

ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study

ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)